Penserra Capital Management LLC Athenex, Inc. Transaction History

Penserra Capital Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 15, 2022	SELL	$1.36 - $2.94 $3,406 - $7,364	-2,505 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$2.97 - $4.84 $1,113 - $1,815	375 Added 17.61%	2,505 $7,000
Q2 2021 Aug 12, 2021	BUY	$3.71 - $5.13 $55 - $76	15 Added 0.71%	2,130 $9,000
Q1 2021 May 13, 2021	SELL	$4.08 - $14.75 $102 - $368	-25 Reduced 1.17%	2,115 $9,000
Q4 2020 Feb 12, 2021	BUY	$11.06 - $14.01 $15,948 - $20,202	1,442 Added 206.59%	2,140 $23,000
Q3 2020 Nov 13, 2020	BUY	$10.26 - $14.55 $7,161 - $10,155	698 New	698 $8,000

1.46M

Ticker ATNX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 156,790,000
Market Cap $1.57M
Description
Athenex, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for the treatment of cancer. It operates through three segments: Oncology Innovation Platform, Global Supply Chain Platform, and Commercial Platform. The company's Orascovery product candidates include Oral paclitaxel and encequidar,...

Get notified when there are updates to the investment portfolio of Penserra Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Penserra Capital Management LLC with notifications on news.